| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7375f1ede4edbf0e5caf1e599f6397d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b938e146229db0980a37904b361ea3d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-3156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
2021-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e3ea34fd6b0f11fef7723778867815b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53684b52bfc412bae45fe6d0601e83ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_244442a04e062501d1ee070a43ae3358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_607ea2dba42098273d942abca502759b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5a5997ccc8541389d3a1dfe12e224b6 |
| publicationDate |
2021-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021214179-A2 |
| titleOfInvention |
Synthetic streptococcus pneumoniae saccharide conjugates to conserved membrane protein |
| abstract |
The present invention relates to conjugates of synthetic Streptococcus pneumoniae oligosaccharides with pneumococcal carrier proteins such as detoxified pneumolysin or pneumococcal surface protein A, and to immunogenic compositions comprising the same. The disclosed conjugates are useful for the prevention and/or treatment of diseases caused by Streptococcus pneumoniae, including Streptococcus pneumoniae serotypes 2 and 3. |
| priorityDate |
2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |